CNTT.Q Stock Overview
Produces and distributes medical and recreational cannabis in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CannTrust Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.005 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 33 Year Change | -99.99% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNTT.Q | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.6% |
| 1Y | 0% | 14.2% | 32.3% |
Return vs Industry: CNTT.Q underperformed the US Pharmaceuticals industry which returned 13.7% over the past year.
Return vs Market: CNTT.Q underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| CNTT.Q volatility | |
|---|---|
| CNTT.Q Average Weekly Movement | 2,940.8% |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CNTT.Q's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CNTT.Q's weekly volatility has decreased from 16038% to 2941% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Corne Melissen | www.canntrust.ca |
CannTrust Holdings Inc. produces and distributes medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is based in Vaughan, Canada.
CannTrust Holdings Inc. Fundamentals Summary
| CNTT.Q fundamental statistics | |
|---|---|
| Market cap | US$141.00 |
| Earnings (TTM) | -US$8.69m |
| Revenue (TTM) | US$38.97m |
0.0x
P/S Ratio0.0x
P/E RatioIs CNTT.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNTT.Q income statement (TTM) | |
|---|---|
| Revenue | CA$54.66m |
| Cost of Revenue | CA$5.48m |
| Gross Profit | CA$49.18m |
| Other Expenses | CA$61.37m |
| Earnings | -CA$12.19m |
Last Reported Earnings
Mar 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CNTT.Q perform over the long term?
See historical performance and comparison